• Developed a quantitative multi-indicator evaluation model for clinical trial management, integrating risk monitoring, quality management, and effectiveness.
• Utilized analytic hierarchy process (AHP) to assign weights to indicators, ensuring objective and reliable assessment.
• Validated the model across multiple trial centers, demonstrating its ability to discriminate between high and low management performance.
• Provides a practical framework for continuous improvement in clinical trial operations, enhancing patient safety and data integrity.
Download Full PDF: Quantitative Management Level Evaluation Model for Clinical Trials: A Multi-Indicator Approach | SinoBioData | SinoBioData